Jane Street Group LLC lowered its stake in shares of Amplify Weight Loss Drug & Treatment ETF (NYSEARCA:THNR – Free Report) by 31.4% during the third quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 14,553 shares of the company’s stock after selling 6,656 shares during the quarter. Jane Street Group LLC’s holdings in Amplify Weight Loss Drug & Treatment ETF were worth $390,000 at the end of the most recent quarter.
Separately, Harbour Investments Inc. lifted its position in Amplify Weight Loss Drug & Treatment ETF by 43.4% during the 3rd quarter. Harbour Investments Inc. now owns 9,563 shares of the company’s stock worth $256,000 after acquiring an additional 2,895 shares during the period.
Amplify Weight Loss Drug & Treatment ETF Price Performance
NYSEARCA:THNR opened at $22.67 on Wednesday. Amplify Weight Loss Drug & Treatment ETF has a 12-month low of $22.00 and a 12-month high of $28.19. The stock’s 50 day simple moving average is $23.82 and its 200-day simple moving average is $25.68.
Recommended Stories
- Five stocks we like better than Amplify Weight Loss Drug & Treatment ETF
- What Does a Gap Up Mean in Stocks? How to Play the Gap
- Disney: Forging a 3-Headed Sports Streaming Giant With Fubo Deal
- What is MarketRank™? How to Use it
- How Buffett’s Best and Worst Stock Bets Have Fared 5 Years Later
- How to Effectively Use the MarketBeat Ratings Screener
- Bill Ackman’s Bold Case for Fannie Mae and Freddie Mac
Receive News & Ratings for Amplify Weight Loss Drug & Treatment ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Amplify Weight Loss Drug & Treatment ETF and related companies with MarketBeat.com's FREE daily email newsletter.
